Clinical Report: Cholinergic Influence on Neuroinflammation

Overview

This review explores the cholinergic anti-inflammatory pathway's role in neuroinflammation, emphasizing its impact on microglial activity and immunometabolic processes.

Background

Neuroinflammation is a critical factor in the progression of numerous neurological disorders, including neurodegenerative diseases and stroke. The cholinergic anti-inflammatory pathway represents a significant area of research, linking neural activity with immune regulation.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

• Microglia are central to the cholinergic regulation of neuroinflammation.
• The cholinergic anti-inflammatory pathway extends beyond the peripheral vagus nerve-mediated reflex.
• Cholinergic signaling influences microglial activation and metabolic processes.
• Pharmacological and bioelectronic methods targeting cholinergic receptors are emerging as therapeutic strategies.
• Cholinergic receptors on microglia and astrocytes play a role in neuroimmune communication.

Clinical Implications

The findings suggest that targeting cholinergic signaling may offer new avenues for therapeutic intervention in neuroinflammatory conditions. Understanding the role of microglia in this context is crucial for developing effective treatments.

Conclusion

The review provides a comprehensive framework for understanding the cholinergic influence on neuroinflammation, highlighting its potential for future therapeutic strategies.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- Mechanisms and therapeutic advances of gut metabolites in the regulation of neuroimmune inflammatory diseases
2. Archives of Toxicology, 2023 -- The Role of Inflammation in the Advancement of Neurological Disorders
3. Frontiers in Immunology, 2026 -- The Tango of Immune and Neural Cells: Orchestrating Neuroinflammation Mediated Brain Disorders
4. Frontiers in Immunology, 2026 -- Editorial: Host-microbe immunometabolic chat: a new era of organismal communication
5. Premarket Approval (PMA), 2025 -- FDA Approval of Implantable Vagus Nerve Stimulation System
6. Transcutaneous Auricular Vagus Nerve Stimulation Reduces Inflammatory Biomarkers after Large Vessel Occlusion Stroke: Results of a Prospective Randomized Open-Label Blinded Endpoint Trial - PMC
7. Premarket Approval (PMA)
8. Transcutaneous Auricular Vagus Nerve Stimulation Reduces Inflammatory Biomarkers after Large Vessel Occlusion Stroke: Results of a Prospective Randomized Open-Label Blinded Endpoint Trial - PMC
9. This guideline is undergoing professional copyediting. The final version will be released in 2025.The American Psychiatric Association